Domenichini Giulia, Diemberger Igor, Biffi Mauro, Martignani Cristian, Valzania Cinzia, Bertini Matteo, Saporito Davide, Ziacchi Matteo, Branzi Angelo, Boriani Giuseppe
Institute of Cardiology, University of Bologna, Azienda Ospedaliera S. Orsola-Malpighi, Italy.
Ann Noninvasive Electrocardiol. 2010 Apr;15(2):101-6. doi: 10.1111/j.1542-474X.2010.00349.x.
Clinicians may be tempted to consider a positive head-up tilt test (HUTT) an unfavorable prognostic indicator. We investigated whether results of routine HUTT predict long-term recurrence of syncope.
We analyzed syncope recurrence at long-term among 107 patients (mean age 51 +/- 20 years) receiving HUTT for diagnostic evaluation of unexplained/suspected neurocardiogenic syncope in our Institute.
HUTT was positive in 76 patients (vasodepressive response, n = 58; cardioinhibitory, n = 5; mixed, n = 13). During a median follow-up of 113 months (range, 7-161), 34 (32%) patients experienced recurrence (24 [32%] with positive HUTT during 110 months (7-159); 10 [32%] with negative HUTT during 120 [22-161] months). Actuarial freedom from recurrence at 10 years did not significantly differ for patients with positive/negative test results (after passive/active phases) or with different positive response patterns (vasodepressive, cardioinhibitory, mixed). By contrast, history of >4 syncopes in the 12 months preceding HUTT stratified risk of recurrence, irrespective of HUTT positivity/negativity. At Cox proportional hazards analysis, history of >4 syncopes in the 12 months preceding HUTT was the single independent risk factor for recurrence both in the overall study population (HR, 1.7; 95% CI, 1.07-2.69) and within the subset of patients who tested positive (HR, 1.83; 95% CI, 1.07-3.17).
This long-term follow-up study reinforces the concept that a positive HUTT should not be considered an unfavorable prognostic indicator; frequency of recent occurrences may be a more valid predictor.
临床医生可能倾向于将直立倾斜试验(HUTT)阳性视为不良预后指标。我们调查了常规HUTT结果是否能预测晕厥的长期复发情况。
我们分析了在我院因不明原因/疑似神经心源性晕厥接受HUTT诊断评估的107例患者(平均年龄51±20岁)的长期晕厥复发情况。
76例患者HUTT呈阳性(血管抑制反应,n = 58;心脏抑制,n = 5;混合型,n = 13)。在中位随访113个月(范围7 - 161个月)期间,34例(32%)患者出现复发(24例[32%]HUTT阳性,随访110个月[7 - 159个月];10例[32%]HUTT阴性,随访120[22 - 161]个月)。试验结果为阳性/阴性(被动/主动阶段后)或不同阳性反应模式(血管抑制型、心脏抑制型、混合型)的患者,10年无复发的精算概率无显著差异。相比之下,HUTT前12个月内晕厥发作>4次的病史可分层复发风险,与HUTT阳性/阴性无关。在Cox比例风险分析中,HUTT前12个月内晕厥发作>4次的病史是整个研究人群(HR,1.7;95%CI,1.07 - 2.69)以及检测呈阳性患者亚组(HR,1.83;95%CI,1.07 - 3.17)中复发的唯一独立危险因素。
这项长期随访研究强化了这样一个概念,即HUTT阳性不应被视为不良预后指标;近期发作频率可能是一个更有效的预测指标。